Fonofos
|
CAS
944-22-9
|
C10H15OPS2
|
RTECS
TA5950000
|
Synonyms & Trade Names
Dyfonate®; Dyphonate; O-Ethyl-S-phenyl ethylphosphorothioate; Fonophos
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL: TWA 0.1 mg/m3 [skin]
|
|
OSHA PEL†: none
|
IDLH
N.D.
See: IDLH INDEX
|
Conversion
1 ppm = 10.07 mg/m3
|
Physical Description
Light-yellow liquid with an aromatic odor. [insecticide]
|
MW: 246.3
|
BP: ?
|
FRZ: ?
|
Sol: 0.001%
|
VP(77°F): 0.0002 mmHg
|
IP: ?
|
|
Sp.Gr: 1.15
|
Fl.P: >201°F
|
UEL: ?
|
LEL: ?
|
|
|
Class IIIB Combustible Liquid: Fl.P. at or above 200°F.
|
Incompatibilities & Reactivities
None reported
|
Measurement Methods
NIOSH 5600; OSHA PV2027
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
Not available.
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Nausea, vomiting, abdominal cramps, diarrhea, salivation; headache, dizziness, lassitude (weakness, exhaustion); rhinorrhea (discharge of thin mucus), chest tightness; blurred vision, miosis; cardiac irregularities; muscle fasciculation; dyspnea (breathing difficulty)
|
Target Organs
respiratory system, central nervous system, cardiovascular system, blood cholinesterase
|
|
See also: INTRODUCTION
See ICSC CARD: 0708 |
